Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 11, 2020 06:15PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
To put a button on this :
"Nothing in your reply proves that ZHCLF is the US version of ZENI-P."
This should tie ZHCLF and ZENI as being the same. The google search engine needs to be corrected, which confuses the Zenith we know out of Alberta and the other Zenith out of BC. Two separate companies.
OTCMarkets" https://www.otcmarkets.com/stock/ZHCLF/security
Sorry to belabour this issue. It keeps coming up time and time again.
Koo